Healthcare provider profile · identity verified

Dmitriy Zilber, MD

Internal Medicine · BEVERLY, MA · NPI 1659462083

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	667	202
Amlodipine Besylate	Amlodipine Besylate	559	147
Lisinopril	Lisinopril	471	150
Simvastatin	Simvastatin	433	121
Losartan Potassium	Losartan Potassium	432	118
Levothyroxine Sodium	Levothyroxine Sodium	320	87
Omeprazole	Omeprazole	311	95
Gabapentin	Gabapentin	251	56
Metoprolol Succinate	Metoprolol Succinate	233	69
Metformin Hcl	Metformin Hcl	209	65
Eliquis	Apixaban	187	38
Tamsulosin Hcl	Tamsulosin Hcl	181	54
Albuterol Sulfate Hfa	Albuterol Sulfate	161	66
Hydrochlorothiazide	Hydrochlorothiazide	161	50
Atenolol	Atenolol	150	43
Rosuvastatin Calcium	Rosuvastatin Calcium	145	50
Furosemide	Furosemide	140	40
Sertraline Hcl	Sertraline Hcl	138	27
Metoprolol Tartrate	Metoprolol Tartrate	132	41
Allopurinol	Allopurinol	131	36
Trazodone Hcl	Trazodone Hcl	124	31
Fluticasone Propionate	Fluticasone Propionate	120	36
Pravastatin Sodium	Pravastatin Sodium	118	29
Glipizide	Glipizide	114	36
Alprazolam	Alprazolam	113	23
Pantoprazole Sodium	Pantoprazole Sodium	113	32
Lorazepam	Lorazepam	103	32
Citalopram Hbr	Citalopram Hydrobromide	102	26
Mirtazapine	Mirtazapine	100	28
Warfarin Sodium	Warfarin Sodium	96	27
Ozempic	Semaglutide	94	16
Metformin Hcl Er	Metformin Hcl	86	24
Trulicity	Dulaglutide	86	18
Escitalopram Oxalate	Escitalopram Oxalate	85	23
Chlorthalidone	Chlorthalidone	84	25
Ezetimibe	Ezetimibe	84	23
Finasteride	Finasteride	83	21
Oxycodone Hcl	Oxycodone Hcl	80	23
Xarelto	Rivaroxaban	79	19
Clopidogrel	Clopidogrel Bisulfate	76	13
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	76	26
Doxazosin Mesylate	Doxazosin Mesylate	75	20
Pregabalin	Pregabalin	73	11
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	65	suppressed
Prednisone	Prednisone	63	29
Buspirone Hcl	Buspirone Hcl	58	22
Carvedilol	Carvedilol	58	18
Famotidine	Famotidine	57	12
Jardiance	Empagliflozin	54	17
Potassium Chloride	Potassium Chloride	54	17
Clonazepam	Clonazepam	53	15
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	53	16
Irbesartan	Irbesartan	52	17
Duloxetine Hcl	Duloxetine Hcl	51	12
Triamcinolone Acetonide	Triamcinolone Acetonide	51	18
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	49	42
Doxycycline Hyclate	Doxycycline Hyclate	49	38
Hydralazine Hcl	Hydralazine Hcl	49	suppressed
Montelukast Sodium	Montelukast Sodium	48	suppressed
Tramadol Hcl	Tramadol Hcl	45	19
Terazosin Hcl	Terazosin Hcl	44	13
Fluoxetine Hcl	Fluoxetine Hcl	43	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	42	11
Ibuprofen	Ibuprofen	40	13
Lovastatin	Lovastatin	40	11
Ondansetron Hcl	Ondansetron Hcl	40	11
Felodipine Er	Felodipine	39	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	39	suppressed
Alendronate Sodium	Alendronate Sodium	38	14
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	38	suppressed
Morphine Sulfate Er	Morphine Sulfate	36	suppressed
Spironolactone	Spironolactone	36	15
Ketoconazole	Ketoconazole	35	13
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	34	suppressed
Valacyclovir	Valacyclovir Hcl	34	11
Ciprofloxacin Hcl	Ciprofloxacin Hcl	33	31
Meclizine Hcl	Meclizine Hcl	33	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	33	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	31	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	31	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	31	suppressed
Diclofenac Sodium	Diclofenac Sodium	30	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	30	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	29	29
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	28	24
Azelastine Hcl	Azelastine Hcl	26	14
Bupropion Hcl Sr	Bupropion Hcl	26	suppressed
Ventolin Hfa	Albuterol Sulfate	26	11
Betamethasone Dipropionate	Betamethasone Dipropionate	25	14
Entresto	Sacubitril/Valsartan	25	suppressed
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	23	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	23	suppressed
Naproxen	Naproxen	23	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	23	suppressed
Azithromycin	Azithromycin	22	19
Glipizide Er	Glipizide	22	suppressed
Methotrexate	Methotrexate Sodium	22	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	22	17
Synthroid	Levothyroxine Sodium	22	suppressed
Topiramate	Topiramate	22	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	22	suppressed
Incruse Ellipta	Umeclidinium Bromide	21	suppressed
Loperamide	Loperamide Hcl	21	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	20	suppressed
Valsartan	Valsartan	20	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	19	suppressed
Bupropion Xl	Bupropion Hcl	19	suppressed
Novolog Flexpen	Insulin Aspart	19	suppressed
Breo Ellipta	Fluticasone/Vilanterol	18	suppressed
Naloxone Hcl	Naloxone Hcl	18	18
Propranolol Hcl	Propranolol Hcl	18	suppressed
Torsemide	Torsemide	18	suppressed
Cephalexin	Cephalexin	17	17
Hydrocortisone	Hydrocortisone	17	suppressed
Clonidine	Clonidine	16	suppressed
Ipratropium Bromide	Ipratropium Bromide	16	suppressed
Ropinirole Hcl	Ropinirole Hcl	16	suppressed
Amoxicillin	Amoxicillin	15	suppressed
Donepezil Hcl	Donepezil Hcl	15	suppressed
Januvia	Sitagliptin Phosphate	15	suppressed
Lamotrigine	Lamotrigine	15	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	15	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	14	suppressed
Colchicine	Colchicine	14	suppressed
Paroxetine Hcl	Paroxetine Hcl	14	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	13	suppressed
Celecoxib	Celecoxib	13	suppressed
Erythromycin	Erythromycin Base	13	12
Isosorbide Dinitrate	Isosorbide Dinitrate	13	suppressed
Clonidine Hcl	Clonidine Hcl	12	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	12	suppressed
Enoxaparin Sodium	Enoxaparin Sodium	12	suppressed
Naltrexone Hcl	Naltrexone Hcl	12	suppressed
Risperidone	Risperidone	12	suppressed
Symbicort	Budesonide/Formoterol Fumarate	12	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	12	suppressed
Buprenorphine-Naloxone	Buprenorphine Hcl/Naloxone Hcl	11	suppressed
Bupropion Hcl	Bupropion Hcl	11	suppressed
Combivent Respimat	Ipratropium/Albuterol Sulfate	11	suppressed
Icosapent Ethyl	Icosapent Ethyl	11	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	11	suppressed
Metronidazole	Metronidazole	11	suppressed
Nitroglycerin	Nitroglycerin	11	suppressed
Paxlovid (Eua)	Nirmatrelvir/Ritonavir	11	11
Phenobarbital	Phenobarbital	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error